TNGX Insider Trading Activity and SEC Form 4 Filings
TNGX insider trading summary
Over the past 12 months, insiders at Tango Therapeutics, Inc. (TNGX) reported 28 sales worth $7.7M by 4 insiders and no open-market purchases on SEC Form 4. Net insider selling was $7.7M.
Latest TNGX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 2, 2026 | Jessica Newcomb | Principal Accounting Officer | Sell | $124K (5,571 @ $22.28) |
| Nov 2, 2026 | Adam Crystal | President, R&D | Sell | $87K (3,900 @ $22.26) |
| Nov 2, 2026 | Jessica Newcomb | Principal Accounting Officer | Sell | $34K (1,460 @ $22.98) |
| Nov 2, 2026 | Adam Crystal | President, R&D | Sell | $25K (1,100 @ $22.99) |
| Oct 1, 2026 | Adam Crystal | President, R&D | Sell | $646K (26,400 @ $24.45) |
| Oct 1, 2026 | Adam Crystal | President, R&D | Sell | $15K (600 @ $25.32) |
| Sep 22, 2026 | Jessica Newcomb | Principal Accounting Officer | Sell | $122K (5,100 @ $23.97) |
| Sep 22, 2026 | Jessica Newcomb | Principal Accounting Officer | Sell | $60K (2,400 @ $25.17) |
| Sep 22, 2026 | Jessica Newcomb | Principal Accounting Officer | Sell | $16K (700 @ $22.80) |
| Sep 1, 2026 | Adam Crystal | President, R&D | Sell | $604K (27,000 @ $22.37) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.